News Boehringer looks to cancer immunotherapy combinations BI developing combinations with its own checkpoint inhibitors
Events Partner Content Rational Combinations 360° The Conference Forum is delighted to present the 2nd annual Rational Combinations 360°, the only event addressing business aspects, novel clinical trial designs and scientific deve
News BMS suffers further setback in lung cancer No fast approval for immunotherapy combo in first line use.
Views & Analysis To you it's a document; to me it's my life Proactive and included patients can help clinical trial retention.
News Merrimack goes back to drawing board with $1bn Ipsen sell-of... Merrimack sells off Onivyde and generic cancer drug
Partner Content Partner Content Immuno-Oncology: A 360° View in NYC this February The Conference Forum has announced that the 3rd annual
News uniQure falls on long-term Huntington's gene therapy data uniQure's latest data drop for its gene therapy for Huntington's disease, under review in the US and UK, has spooked investors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
